The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab.

A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes.

Treasure or artifact: a decade of p63 research speaks for itself.

Pathogenic role of interleukin-21 in psoriasis.

Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience.

The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting.

Downregulation of DeltaNp63alpha in keratinocytes by p14ARF-mediated SUMO-conjugation and degradation.

Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia.

Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain.

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.